XENiOS
VC Fund
Heilbronn, Germany
XENiOS is a VC fund in Heilbronn focused on Medical and Health Care. XENiOS AG developer of extracorporeal therapy systems., because the heart and the lungs are linked anatomically the right heart (ventricle) perfuses the lungs, while the left heart (ventricle) perfuses the body. No other company except XENIOS AG is offering minimally invasive disposable lung and heart therapies on one single platform.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries XENiOS invests in
Stages XENiOS invests in
Countries XENiOS invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dr. Benjamin Waldmann
|
|||
Georg Matheis
|
|||
|
Josef Bogenschuetz
|
|||
Jurgen Bohm
|
|||
Knut Jöchle
|
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Health Diagnostics 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Dr. Benjamin Waldmann
CEO
|
CEO | Total investments: 0 | Find email | |
|
Georg Matheis
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Josef Bogenschuetz
CEO & President
|
CEO & President | Total investments: 0 | Find email | |
|
Jurgen Bohm
Managing Directo, Chief Marketing and Medical Officer
|
Managing Directo, Chief Marketing and Medical Officer | Total investments: 0 | Find email | |
|
Knut Jöchle
Vice President - Product Life Cycle & Quality Processes
|
Vice President - Product Life Cycle & Quality Processes | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Advances in medical science have introduced the era of personalized medicine for organs. XOR Labs Toronto is a pioneer in this field. We are changing the face of organ transplantation by exponentially increasing the number of donated lungs available for transplantation around the world. | $2.2M / Venture - Series Unknown / Sep 21, 2016 | ||
| Advances in medical science have introduced the era of personalized medicine for organs. XOR Labs Toronto is a pioneer in this field. We are changing the face of organ transplantation by exponentially increasing the number of donated lungs available for transplantation around the world. | $1.9M / Venture - Series Unknown / Feb 22, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does XENiOS invest in?
XENiOS invests primarily in Medical, Health Care and Health Diagnostics startups, most often at Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact XENiOS?
Public channels for XENiOS include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at XENiOS?
The team at XENiOS includes Dr. Benjamin Waldmann (CEO), Georg Matheis (Managing Director) and Josef Bogenschuetz (CEO & President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
